News
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...
Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...
10h
Sportschosun on MSNStress Resilience Finds Clues in the Brain...Specific proteins play a key role in regulating flexibl...Researchers in Korea have discovered clues in the brain that affect stress resilience. This is the result of the research ...
2h
Zacks Small Cap Research on MSNNNVC: NanoViricides Set to Initiate Phase 2 Trial in MPoxNNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results